Your browser doesn't support javascript.
loading
Enhanced soluble expression of active recombinant human interleukin-29 using champion pET SUMO system.
Munir, Ayesha; Ahmed, Nadeem; Akram, Muhammad; Fujimura, Nao Akusa; Tahir, Saad; Malik, Kausar.
Affiliation
  • Munir A; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
  • Ahmed N; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan. nadeem.ahmed@cemb.edu.pk.
  • Akram M; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
  • Fujimura NA; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
  • Tahir S; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
  • Malik K; Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Biotechnol Lett ; 45(8): 1001-1011, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37266881
ABSTRACT
Current research focuses on the soluble and high-level expression of biologically active recombinant human IL-29 protein in Escherichia coli. The codon-optimized IL-29 gene was cloned into the Champion™ pET SUMO expression system downstream of the SUMO tag under the influence of the T7 lac promoter. The expression of SUMO-fused IL-29 protein was compared in E. coli Rosetta 2(DE3), Rosetta 2(DE3) pLysS, and Rosetta-gami 2(DE3). The release of the SUMO fusion partner resulted in approximately 98 mg of native rhIL-29 protein with a purity of 99% from 1 l of fermentation culture. Purified rhIL-29 was found to be biologically active, as evaluated by its anti-proliferation assay. It was found that Champion™ pET SUMO expression system can be used to obtained high yield of biologically active soluble recombinant human protein compared to other expression vector.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Interleukins / Escherichia coli Limits: Humans Language: En Journal: Biotechnol Lett Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Interleukins / Escherichia coli Limits: Humans Language: En Journal: Biotechnol Lett Year: 2023 Document type: Article